Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-04 Sale | 2024-04-08 7:32 pm | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 165 | $2.6211 | $432 | 16,327 (Direct) | View |
| 2024-04-04 Sale | 2024-04-08 7:32 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 5,268 | $2.624 | $13,823 | 8,655,189 (Indirect Direct) | View |
| 2024-04-04 Sale | 2024-04-08 7:32 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 1,069 | $2.635 | $2,817 | 15,684 (Direct) | View |
| 2024-04-04 Sale | 2024-04-08 7:31 pm | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | 1,008 | $2.6351 | $2,656 | 11,992 (Direct) | View |
| 2024-04-04 Sale | 2024-04-08 7:30 pm | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 1,012 | $2.6358 | $2,667 | 18,591 (Direct) | View |
| 2024-04-04 Sale | 2024-04-08 7:30 pm | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 1,067 | $2.635 | $2,812 | 23,682 (Direct) | View |
| 2023-06-15 Sale | 2023-06-16 6:40 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 60,000 | $20.86 | $1,251,727 | 688,607 (Indirect Direct) | View |
| 2023-05-22 Sale | 2023-05-24 4:37 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 6,500 | $25.79 | $167,641 | 39,294 (Indirect Direct) | View |
| 2023-05-15 Sale | 2023-05-16 8:32 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 5,000 | $27.17 | $135,864 | 1,500 (Direct) | View |
| 2023-05-15 Sale | 2023-05-16 8:29 pm | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 1,785 | $27.32 | $48,765 | 4,350 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-14 Exercise | 2024-04-08 7:32 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks | 2,771 | $0 | 16,327 (Direct) | View |
| 2024-03-14 Exercise | 2024-04-08 7:32 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 16,610 | $0 | 8,655,189 (Direct) | View |
| 2024-03-14 Exercise | 2024-04-08 7:32 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 2,771 | $0 | 15,684 (Direct) | View |
| 2024-03-15 Exercise | 2024-04-08 7:31 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | 3,000 | $0 | 11,992 (Direct) | View |
| 2024-03-14 Exercise | 2024-04-08 7:30 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 2,771 | $0 | 18,591 (Direct) | View |
| 2024-03-14 Exercise | 2024-04-08 7:30 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 2,771 | $0 | 23,682 (Direct) | View |
| 2023-12-14 Exercise | 2023-12-18 4:57 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 521 | $0 | 15,749 (Direct) | View |
| 2023-12-14 Exercise | 2023-12-18 4:55 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 2,609 | $0 | 8,604,457 (Direct) | View |
| 2023-12-14 Exercise | 2023-12-18 4:54 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 521 | $0 | 10,603 (Direct) | View |
| 2023-12-14 Exercise | 2023-12-18 4:52 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 521 | $0 | 7,753 (Direct) | View |
| 2023-12-14 Exercise | 2023-12-18 4:47 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 521 | $0 | 7,492 (Direct) | View |
| 2023-09-14 Exercise | 2023-09-18 4:49 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 521 | $0 | 15,749 (Direct) | View |
| 2023-09-14 Exercise | 2023-09-18 4:49 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 521 | $0 | 7,753 (Direct) | View |
| 2023-09-14 Exercise | 2023-09-18 4:48 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 521 | $0 | 10,603 (Direct) | View |
| 2023-09-14 Exercise | 2023-09-18 4:47 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 521 | $0 | 7,492 (Direct) | View |
| 2023-09-14 Exercise | 2023-09-18 4:47 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 2,610 | $0 | 57,707 (Direct) | View |
| 2023-06-26 Option Award | 2023-06-28 5:02 pm | N/A 2033-06-26 | BioXcel Therapeutics Inc. | BTAI | Bray June Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-26 Option Award | 2023-06-28 5:01 pm | N/A 2033-06-26 | BioXcel Therapeutics Inc. | BTAI | MUELLER PETER Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-26 Option Award | 2023-06-28 4:59 pm | N/A 2033-06-26 | BioXcel Therapeutics Inc. | BTAI | MILLER MICHAEL PATRICK Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-26 Option Award | 2023-06-28 4:58 pm | N/A 2033-06-26 | BioXcel Therapeutics Inc. | BTAI | Laumas Sandeep Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-26 Other | 2023-06-28 4:56 pm | N/A 2033-06-26 | BioXcel Therapeutics Inc. | BTAI | Votruba Michal Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-26 Option Award | 2023-06-28 4:56 pm | N/A 2033-06-26 | BioXcel Therapeutics Inc. | BTAI | Votruba Michal Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-14 Exercise | 2023-06-16 6:46 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 521 | $0 | 10,603 (Direct) | View |
| 2023-06-14 Exercise | 2023-06-16 6:44 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 521 | $0 | 15,749 (Direct) | View |
| 2023-06-14 Exercise | 2023-06-16 6:42 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 521 | $0 | 7,753 (Direct) | View |
| 2023-06-14 Exercise | 2023-06-16 6:40 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 62,609 | $0 | 688,607 (Direct) | View |
| 2023-06-15 Exercise | 2023-06-16 6:40 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 60,000 | $0.41 | 688,607 (Direct) | View |
| 2023-06-14 Exercise | 2023-06-16 6:36 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 521 | $0 | 7,492 (Direct) | View |
| 2023-05-14 Exercise | 2023-05-16 8:33 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 15,000 | $0 | 32,894 (Direct) | View |
| 2023-05-14 Exercise | 2023-05-16 8:32 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 5,000 | $0 | 1,500 (Direct) | View |
| 2023-05-14 Exercise | 2023-05-16 8:29 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 5,000 | $0 | 4,350 (Direct) | View |
Ownership | 2023-04-26 3:19 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Aiello Michael James 10% Owner | 0 | $0 | 8,546,750 (Indirect) | View |
Ownership | 2023-04-14 11:30 am | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Balasubramanian Suganthi 10% Owner | 0 | $0 | 8,547,750 (Indirect) | View |
Ownership | 2023-04-13 7:52 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Agarwal Rashmi 10% Owner | 0 | $0 | 8,554,945 (Direct) | View |
Ownership | 2023-04-13 7:51 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Agarwal Anesha 10% Owner | 0 | $0 | 8,546,750 (Indirect) | View |
Ownership | 2023-04-13 7:24 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Sood Pardeep Kumar 10% Owner | 0 | $0 | 8,546,750 (Indirect) | View |
Ownership | 2023-04-13 7:21 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Sood Alka 10% Owner | 0 | $0 | 8,546,750 (Indirect) | View |
Ownership | 2023-04-13 7:16 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Patel Krunal Dilip 10% Owner | 0 | $0 | 8,546,750 (Indirect) | View |
Ownership | 2023-04-13 7:14 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Patel Jatin Markand 10% Owner | 0 | $0 | 8,547,750 (Indirect) | View |
Ownership | 2023-04-13 7:12 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Patel Bina Jatin 10% Owner | 0 | $0 | 8,547,750 (Indirect) | View |
Ownership | 2023-04-13 7:10 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Jain Diwakar 10% Owner | 0 | $0 | 8,547,300 (Direct) | View |